- RXST Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
RxSight (RXST) S-8Registration of securities for employees
Filed: 29 Feb 24, 12:00am
As filed with the Securities and Exchange Commission on February 28, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S‑8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
RXSIGHT, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
| 94-3268801 |
(State or other jurisdiction of |
| (I.R.S. Employer |
100 Columbia
Aliso Viejo, CA 92656
(949) 521-7830
(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
2021 Equity Incentive Plan
(Full title of the plan)
Ron Kurtz, M.D.
President and Chief Executive Officer
RxSight, Inc.
100 Columbia
Aliso Viejo, CA 92656
(949) 521-7830
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
Martin J. Waters Robert L. Wernli, Jr. Wilson Sonsini Goodrich & Rosati, P.C. 12235 El Camino Real San Diego, CA 92130 (858) 350-2300 |
| Shelley Thunen Chief Financial Officer RxSight, Inc. 100 Columbia Aliso Viejo, CA 92656 (949) 521-7830 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ |
| Accelerated filer | ☐ |
Non-accelerated filer | ☐ |
| Smaller reporting company | ☐ |
|
|
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.☐
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
This Registration Statement on Form S-8 (the “Registration Statement”) is filed by RxSight, Inc. (the “Registrant”) for the purpose of registering 1,445,580 additional shares of common stock of the Registrant that may be issued pursuant to the RxSight, Inc. 2021 Equity Incentive Plan.
In accordance with General Instruction E to Form S-8, the contents of the previous Registration Statements on Form S-8 filed by the Registrant with the Securities and Exchange Commission (the “SEC”) on July 30, 2021 (File No. 333-258292), Form S-8 filed by the Registrant with the SEC on March 8, 2022 (File No. 333-263374) and Form S-8 filed by the Registrant with the SEC on March 6, 2023 (File No. 333-270301) are incorporated by reference into this Registration Statement.
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the SEC:
All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 8. Exhibits.
Exhibit |
| Incorporated by Reference | |||
Number | Description | Form | File No. | Exhibit | Filing Date |
|
|
|
|
|
|
4.1 | S-1/A | 333-257790 | 4.2 | July 26, 2021 | |
4.2 | 10-Q | 001-40690 | 10.2 | November 10, 2021 | |
5.1* | Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation | ||||
23.1* |
|
|
|
| |
23.2* |
|
|
|
| |
24.1* |
|
|
|
| |
107* |
|
|
|
| |
* | Filed herewith. |
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Aliso Viejo, State of California, on February 28, 2024.
RXSIGHT, INC. | ||
|
| |
By: |
| /s/ Ron Kurtz, M.D. |
|
| Ron Kurtz, M.D. |
|
| President and Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Ron Kurtz, M.D. and Shelley Thunen as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and substitution, for him or her and in their name, place and stead, in any and all capacities, to sign this Registration Statement and any and all amendments thereto (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, and agents or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.
Signature |
| Title |
| Date | |||
|
|
| |||||
/s/ Ron Kurtz, M.D. |
| President, Chief Executive Officer and Director (Principal Executive Officer) |
| February 28, 2024 | |||
Ron Kurtz, M.D. |
|
| |||||
|
|
| |||||
/s/ Shelley Thunen |
| Chief Financial Officer (Principal Financial and Accounting Officer) |
| February 28, 2024 | |||
Shelley Thunen |
|
| |||||
|
|
| |||||
/s/ J. Andy Corley |
| Chair of the Board |
| February 28, 2024 | |||
J. Andy Corley |
|
| |||||
|
|
| |||||
/s/ William J. Link, Ph.D. |
| Director |
| February 28, 2024 | |||
William J. Link, Ph.D. |
|
| |||||
|
|
| |||||
/s/ Juliet Tammenoms Bakker |
| Director |
| February 28, 2024 | |||
Juliet Tammenoms Bakker |
|
| |||||
|
|
| |||||
/s/ Julie Andrews |
| Director |
| February 28, 2024 | |||
Julie Andrews |
|
| |||||
/s/ Robert Palmisano | Director | February 28, 2024 | |||||
Robert Palmisano | |||||||
/s/ Robert Warner |
| Director |
| February 28, 2024 | |||
Robert Warner |
|
|
|
| |||
|
|
|
|
| |||
/s/ Shweta Singh Maniar | Director | February 28, 2024 | |||||
Shweta Singh Maniar | |||||||
|
|
|
|
| |||
/s/ Tamara R. Fountain, M.D. |
| Director |
| February 28, 2024 | |||
Tamara R. Fountain, M.D. |
|
|
|
|